Artiva Biotherapeutics, Inc.ARTVNASDAQ

Loading chart...

Want to monitor ARTV?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

No description available.

Professional, Scientific, and Technical Services

Research and Development in Biotechnology (except Nanobiotechnology)

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

Key Statistics

About

News

Berkshire Hathaway: I'm More Bullish Than Ever

Halozyme Therapeutics: Key Acquisitions To Help Drive Long-Term Growth

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Varonis Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VRNS

My Top 3 Predictions for Nvidia in 2026

Deckers Outdoor: The Reasons Why I Upgrade From Hold To Buy

Hitachi: Buy Reiterated On This Potential SaaS Opportunity

2 Warren Buffett Stocks to Buy Hand Over Fist in February

How Lemonade Stock Gained 22% Last Month

Why AppLovin Stock Lost 30% in January

Gold Hunter Resources Closes Final Tranche of Financing; Fully Funded for Inaugural Drilling Program

Oil Prices Slide as U.S.–Iran Talks Ease Geopolitical Risk and Remove Fear Premium

GRX: Underwhelming Performance Metrics And Inconsistent Dividend Coverage

SoftBank subsidiary to work with Intel on next-gen memory for AI

The Top 5 Stocks to Double Up on Right Now

VB: Bottom-Up And Top-Down Analysis Points To Further Outperformance

WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager

Better Dividend Stock: Energy Transfer vs. Enterprise Products Partners in 2026

Gold and silver rebound after historic wipeout as analysts say thematic drivers stay intact

Google Is Spending Big to Build a Lead in the AI Energy Race

BRBR Investors Have Opportunity to Lead BellRing Brands, Inc. Securities Fraud Lawsuit